FDA Panel Offers Specifics For Revised CAP Trial Guidance, No Big Changes

Design of trials for community-acquired pneumonia drugs would face greater specificity but no major changes according to recommendations from FDA's Anti-Infective Drugs Advisory Committee

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet